Rule, Reynaville C.
HRN: 25-68-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2025
AMPICILLIN 1GM (VIAL)
02/07/2025
02/10/2025
IV
2 Grams
Q6
Prom X 1 Hr, Thickly Msaf
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes